These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31338879)

  • 1. MEK inhibitor cobimetinib rescues a dRaf mutant lethal phenotype in Drosophila melanogaster.
    Pfeifle I; Bohnekamp J; Volkhardt A; Kirsten H; Rohwedder A; Thum A; Magin TM; Kunz M
    Exp Dermatol; 2019 Sep; 28(9):1079-1082. PubMed ID: 31338879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase pathway inhibitors rescue lethal phenotypes in a BRAF gain-of-function Drosophila melanogaster model.
    Volkhardt A; Bohnekamp J; Pfeifle I; Engel C; Magin TM; Kunz M
    Pigment Cell Melanoma Res; 2018 Jul; 31(4):545-548. PubMed ID: 29288529
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer.
    Kawakami H; Huang S; Pal K; Dutta SK; Mukhopadhyay D; Sinicrope FA
    Mol Cancer Ther; 2016 Dec; 15(12):3015-3027. PubMed ID: 27765849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of autosomal regions involved in Drosophila Raf function.
    Li W; Noll E; Perrimon N
    Genetics; 2000 Oct; 156(2):763-74. PubMed ID: 11014822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer.
    Zhang P; Kawakami H; Liu W; Zeng X; Strebhardt K; Tao K; Huang S; Sinicrope FA
    Mol Cancer Res; 2018 Mar; 16(3):378-389. PubMed ID: 29233910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cobimetinib: inhibiting MEK1/2 in BRAF V600-mutant melanoma.
    Eagles JR; Jimeno A
    Drugs Today (Barc); 2016 Nov; 52(11):593-605. PubMed ID: 28112278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
    Rosen LS; LoRusso P; Ma WW; Goldman JW; Weise A; Colevas AD; Adjei A; Yazji S; Shen A; Johnston S; Hsieh HJ; Chan IT; Sikic BI
    Invest New Drugs; 2016 Oct; 34(5):604-13. PubMed ID: 27424159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes.
    Lulli D; Carbone ML; Pastore S
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cobimetinib (GDC-0973, XL518).
    Andrlová H; Zeiser R; Meiss F
    Recent Results Cancer Res; 2018; 211():177-186. PubMed ID: 30069767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.
    Cohen Aubart F; Emile JF; Maksud P; Galanaud D; Cluzel P; Benameur N; Aumaitre O; Amoura Z; Haroche J
    Br J Haematol; 2018 Jan; 180(1):150-153. PubMed ID: 27711968
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells.
    Gong S; Xu D; Zhu J; Zou F; Peng R
    Cell Physiol Biochem; 2018; 47(2):680-693. PubMed ID: 29794421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status.
    Thompson EM; Landi D; Ashley D; Keir ST; Bigner D
    J Neurooncol; 2018 Nov; 140(2):261-268. PubMed ID: 30120661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model.
    Narita Y; Okamoto K; Kawada MI; Takase K; Minoshima Y; Kodama K; Iwata M; Miyamoto N; Sawada K
    Mol Cancer Ther; 2014 Apr; 13(4):823-32. PubMed ID: 24448821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study.
    Dréno B; Ribas A; Larkin J; Ascierto PA; Hauschild A; Thomas L; Grob JJ; Koralek DO; Rooney I; Hsu JJ; McKenna EF; McArthur GA
    Ann Oncol; 2017 May; 28(5):1137-1144. PubMed ID: 28444112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma.
    Amaral T; Nouri N; Garbe C
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):705-15. PubMed ID: 27219630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.
    Okimoto RA; Lin L; Olivas V; Chan E; Markegard E; Rymar A; Neel D; Chen X; Hemmati G; Bollag G; Bivona TG
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13456-13461. PubMed ID: 27834212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The commonly used eye-specific sev-GAL4 and GMR-GAL4 drivers in Drosophila melanogaster are expressed in tissues other than eyes also.
    Ray M; Lakhotia SC
    J Genet; 2015 Sep; 94(3):407-16. PubMed ID: 26440079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model.
    Settle M; Gordon MD; Nadella M; Dankort D; Muller W; Jacobs JR
    Oncogene; 2003 Apr; 22(13):1916-26. PubMed ID: 12673197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobimetinib in malignant melanoma: how to MEK an impact on long-term survival.
    Indini A; Tondini CA; Mandalà M
    Future Oncol; 2019 Mar; 15(9):967-977. PubMed ID: 30638071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells.
    Singh A; Ruan Y; Tippett T; Narendran A
    J Exp Clin Cancer Res; 2015 Sep; 34(1):104. PubMed ID: 26384788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.